Gastroenterology 2026
- Continuing Education
Gastroenterology 2026 provides a comprehensive update for clinicians who care for patients with GI disorders. It covers state-of-the-art clinical strategies, updates and expanded options for treatment and diagnosis, and guidance for complex and unusual cases.
- Live Online
This program uses state-of-the-art streaming technology to present sessions online in real time. Participants can attend from any location, and can interact with faculty via live chat.
Additionally, all sessions will be recorded and made available to participants for online viewing for 90 days after the end of the course.
All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
$1,295
This is the full tuition for physicians. A $100 early registration discount is available.
For tuition for other medical professionals, please see the full table below.
Early Registration Deadline:
Continuing Education Credits
Earn up to:
» 27.25 AMA PRA Category 1 Credits™
» 27.25 ABIM MOC points
» 27.25 ECME Credits®
» Commensurate credits through the Royal College of Physicians and Surgeons of Canada
4 Days
This 4-day intensive course, which is among the highest-rated Harvard Medical School CME courses, presents the most up-to-date, evidence-based approaches to gastrointestinal and hepatobiliary disorders.
On This Page
Overview
The Comprehensive 2026 Gastroenterology Update
Gastroenterology 2026 is a live online course, using live streaming, electronic Q&A, and other remote learning technologies.
This program ensures participants are current with state-of-the-art GI strategies and clinical practices. It covers recent advances and their impact on clinical approaches and on patient outcomes. Updates, best practices, and new guidelines are presented by nationally recognized GI experts and master clinicians.
Practical, Results-Driven Education
Highlights of the 2026 program include:
- The newest guidelines for the use of biologics in IBD
- Therapeutic drug monitoring in IBD treatment
- Management of the older adult with IBD
- Updated guidelines for treatment of C. difficile infection
- Managing GI complications of immunotherapy and anti-neoplastic therapies
- Improved management of IBS
- Tips for managing fecal incontinence
- Management of refractory GERD
- Optimal surveillance in hereditary GI cancer syndromes
- Current treatment of H. pylori
- Updated treatment of HBV and HCV
- Management of steatotic liver disease in 2026
- How to diagnose and manage cirrhosis
- How to improve your adenoma detection rate (ADR)
- Steps to ensure delivery of high-quality colonoscopic care
- Techniques to effectively control acute GI bleeding
- Endoscopic management of obesity
- When FMT is indicated for treatment
- New strategies to treat common GI problems
- A comprehensive update of national guidelines
As new strategies, guidelines, and diagnostic and treatment options are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
Education to Optimize Your Patient Outcomes
The evidence-based recommendations provided in this program cover:
- IBD
- GI Complications of Immunotherapy
- Microscopic Colitis
- Steatotic Liver Disease
- Barrett’s Esophagus
- Eosinophilic Esophagitis
- C. difficile Colitis
- H. pylori Treatment
- Alcohol-Related Liver Disease
- Autoimmune Hepatitis
- IBS
- Refractory GERD
- Acute Pancreatitis
- Chronic Pancreatitis
- Celiac Disease
- GI Bleeding
- High Risk for Colorectal Cancer
Recent Advances and Innovations
Clinicians can rely on this program for education on:
- Biological therapies for IBD: how to choose which agent to start with? How to monitor during treatment? What is the role for therapeutic drug monitoring? When to switch? What new agents are now available?
- GI complications of immunotherapy — a common and heterogeneous disorder: how to approach and treat effectively?
- Eosinophilic esophagitis: how to decide between drug therapy and dietary therapy?
- The stool microbiome: understanding the science behind clinical applications
- Celiac disease: making sense of the multiple serologic tests—new therapeutic strategies are on the horizon
- Adenoma detection rates: critical to measure and how to incorporate strategies, including AI, to increase your rate
- Endoscopic approaches to managing obesity
- Updated treatments for HBV and HCV
This program also offers a glimpse into the future of gastroenterology with engaging lectures given by world-renowned experts on inspiring and cutting-edge topics.
In addition to being live streamed, all sessions will be recorded and placed in the online course library, enabling registrants to view them at their convenience. Recordings will be available for viewing for 90 days after the conclusion of the course. All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
Developed and Offered By:
Continuing Education courses are developed by faculty from Harvard Medical School's teaching hospitals and accredited by Harvard Medical School. This course is offered by Mass General Brigham and Beth Israel Deaconess Medical Center.
Participant Types
- Gastroenterologists
- Internists
- Surgeons
- Nurse Practitioners
- Physician Assistants
Schedule
This program is among the highest-rated Harvard Medical School CME courses.
All schedule times are Eastern Daylight Time.
Please note that program changes / substitutions may be made without notice.
Monday, June 8, 2026
Welcome
Dr. Daniel Chung
8:25-8:30 am
Which Initial Therapy to Choose in Crohn's Disease?
Dr. Joshua Korzenik
8:30-9:10 am
Which Initial Therapy to Choose in Ulcerative Colitis?
Dr. Ashwin Ananthakrishnan
9:10-9:50 am
Putting It Together: Illustrative IBD Case Presentations
Dr. Kristin Burke
9:50-10:20 am
Panel Q&A
Drs. Ashwin Ananthakrishnan, Joshua Korzenik, and Kristin Burke
10:20-10:35 am
Break
10:35-10:50 am
Management of the Older Adult with IBD
Dr. Bharati Kochar
10:50-11:15 am
IBD in Pregnancy
Dr. Loren Rabinowitz
11:15-11:40 am
Therapeutic Drug Monitoring in IBD
Dr. Adam Cheifetz
11:40 am-12:15 pm
Panel Q&A
Drs. Adam Cheifetz, Bharati Kochar, and Loren Rabinowitz
12:15-12:30 pm
Break
12:30-1:30 pm
How to Manage Microscopic Colitis
Dr. Hamed Khalili
1:30-2:00 pm
GI Complications of Immunotherapy
Dr. Michael Dougan
2:00-2:30 pm
GI Complications of Antineoplastic Therapy
Dr. Shilpa Grover
2:30-3:00 pm
Panel Q&A
Drs. Michael Dougan, Hamed Khalili, and Shilpa Grover
3:00-3:15 pm
Break
3:15-3:30 pm
High-Risk Cancer Surveillance in GI Cancer Syndromes
Dr. Daniel Chung
3:30-4:00 pm
CRC Screening and How to Improve Your ADR
Dr. Ramona Lim
4:00-4:30 pm
Beyond Screening: What to Recommend to Reduce Colorectal Cancer Risk
Dr. Andrew Chan
4:30-5:00 pm
Panel Q&A
Drs. Daniel Chung, Ramona Lim, and Andrew Chan
5:00-5:15 pm
Tuesday, June 9, 2026
Barrett's Esophagus: Whom and How to Treat?
Dr. Douglas Pleskow
8:30-9:10 am
Esophageal Motility Disorders Made Easy
Dr. Barbara Nath
9:10-9:40 am
Management of Refractory GERD
Dr. Norman Nishioka
9:40-10:10 am
Panel Q&A
Drs. Douglas Pleskow, Barbara Nath, and Norman Nishioka
10:10-10:25 am
Break
10:25-10:40 am
Comprehensive Approach to Eosinophilic Esophagitis
Dr. Walter Chan
10:40-11:20 am
Celiac Disease and Gluten Sensitivity: 2026 Practitioner Updates
Dr. Ciaran Kelly
11:20 am-12:05 pm
Panel Q&A
Drs. Walter Chan and Ciaran Kelly
12:05-12:20 pm
Break
12:20-1:30 pm
Making the Diagnosis of IBS
Dr. Kyle Staller
1:30-2:00 pm
Modern Strategies to Treat IBS
Dr. Vikram Rangan
2:00-2:30 pm
Tips to Managing Fecal Incontinence
Dr. Kyle Staller
2:30-2:50 pm
Panel Q&A
Drs. Kyle Staller and Vikram Rangan
2:50-3:05 pm
Break
3:05-3:25 pm
Optimizing the Management of Gastroparesis
Dr. Trisha Pasricha
3:25-3:55 pm
How to Evaluate Small Intestinal Bacterial Overgrowth
Dr. Judy Nee
3:55-4:25 pm
Panel Q&A
Drs. Judy Nee and Trisha Pasricha
4:25-4:40 pm
Wednesday, June 10, 2026
Cholestatic Liver Diseases: What's New in PBC and PSC
Dr. Daniel Pratt
8:30-9:00 am
How to Manage Autoimmune Hepatitis
Dr. Alan Bonder
9:00-9:30 am
Updates in the Treatment of HBV and HCV
Dr. Michael Curry
9:30-10:00 am
Panel Q&A
Drs. Daniel Pratt, Alan Bonder, and Michael Curry
10:00-10:15 am
Break
10:15-10:30 am
Alcohol-Associated Liver Disease
Dr. Gyongyi Szabo
10:30-11:10 am
The Management of MASLD
Dr. Kathleen Corey
11:10-11:40 am
Panel Q&A
Drs. Gyongyi Szabo and Kathleen Corey
11:40-11:55 am
Break
11:55 am-1:00 pm
How to Workup a Liver Lesion
Dr. Karin Andersson
1:00-1:30 pm
Diagnosis and Routine Management of Cirrhosis
Dr. Michelle Lai
1:30-2:00 pm
End-Stage Liver Disease and Management of Portal Hypertension
Dr. Anna Rutherford
2:00-2:40 pm
Panel Q&A
Drs. Anna Rutherford, Michelle Lai, and Karin Andersson
2:40-3:00 pm
Break
3:00-3:15 pm
Best Management Strategies in Acute Pancreatitis
Dr. David Jin
3:15-3:45 pm
Updates in Chronic Pancreatitis
Dr. Sunil Sheth
3:45-4:20 pm
Controversies in the Management of Cystic Lesions of the Pancreas
Dr. Carlos Fernandez-del Castillo
4:20-4:50 pm
Panel Q&A
Drs. David Jin, Sunil Sheth, and Carlos Fernandez-del Castillo
4:50-5:05 pm
Thursday, June 11, 2026
Tips to Removing the Difficult Colon Polyp
Dr. Tyler Berzin
8:30-9:10 am
Quality Measures for Colonoscopy: What's New and Why It Matters
Dr. Mandeep Sawhney
9:10-9:40 am
Endoscopy and the Anticoagulated Patient
Dr. Kunal Jajoo
9:40-10:10 am
Panel Q&A
Drs. Tyler Berzin, Mandeep Sawhney, and Kunal Jajoo
10:10-10:25 am
Break
10:25-10:40 am
Acute GI Bleeding and Other GI Emergencies
Dr. Linda Lee
10:40-11:20 am
Advances in Endoscopic Surgery for Foregut Disorders
Dr. Kumar Krishnan
11:20-11:50 am
Endoscopic Approaches to Manage Obesity
Dr. Christopher Thompson
11:50 am-12:20 pm
Panel Q&A
Drs. Christopher Thompson, Kumar Krishnan, and Linda Lee
12:20-12:35 pm
Break
12:35-1:45 pm
What's New in C. Difficile Colitis
Dr. Jessica Allegretti
1:45-2:15 pm
New Insights into the Gut Microbiome and Disease
Dr. Ramnik Xavier
2:15-2:45 pm
GI Cases to Remember
Dr. Douglas Horst
3:15-3:45 pm
Panel Q&A
Drs. Douglas Horst, Jessica Allegretti, Ramnik Xavier, and Jay Luther
3:45-4:00 pm
Optimized for Distance Learning
The 2026 program has been optimized for distance learning.
In addition to being live streamed, all sessions and Q & A discussions will be recorded and made available to participants for online viewing for 90 days after the end of the course. This on-demand archive will permit those in different time zones or who have scheduling conflicts to avoid missing out on any sessions that are important to them. In addition, participants can review sessions to reinforce key learning points.
All live streaming and recorded sessions are eligible for AMA PRA Category 1 Credits™ and other relevant credits. (Note: Evaluations must be completed within 30 days in order to receive CME credit.)
Learning Objectives
Upon completion of this course, participants will be able to:
- Interpret major advances in the field of gastroenterology
- Incorporate the most up-to-date diagnostic approaches to GI disorders
- Identify therapeutic options for GI disorders in an evidence-based manner
- Manage patients with both common and rare GI disorders using established guidelines
Faculty
Course Directors
- Professor of Medicine, Harvard Medical School
- Division of Gastroenterology, Massachusetts General Hospital
Nezam Afdhal
MD
- Professor of Medicine, Harvard Medical School
- Chief, Division of Gastroenterology, Beth Israel Deaconess Medical Center
- Professor of Medicine, Harvard Medical School
- Chief, Division of Gastroenterology, Hepatology & Endoscopy, Mass General Brigham Academic Medical Centers
2026 faculty list coming soon.
Course Fees
Fee Disclaimer
Registrations for Harvard Medical School CME programs are made via our secure online registration system. At the end of the registration process, a $10 non-refundable processing fee will be added to your registration.
Upon receipt of your paid registration, an email confirmation will be sent to you. Be sure to include an email address that you check frequently. Your email address is used for critical information, including registration confirmation, evaluation, and certificate.
Please review the cancellation policy.
Early Registration Deadline:
| Role | Course Fee | Early Registration Course Fee |
|---|---|---|
| Physician (MD/DO) | $1,295.00 | $1,195.00 |
| Nurse (RN/APRN) | $1,195.00 | $1,095.00 |
| PA | $1,195.00 | $1,095.00 |
| Resident/Fellow | $895.00 | $795.00 |
| Allied Health Professional / Other | $1,195.00 | $1,095.00 |
All registrants of Gastroenterology 2026 will receive an electronic syllabus.
All sessions will be recorded as they are live streamed and placed in the online course video library, so that registrants can review them at their convenience. The video library will be available for 90 days after the conclusion of the course.
Accreditation
The Harvard Medical School designates this live activity for a maximum of 27.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 27.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
For the purpose of recertification, the American Academy of Nurse Practitioners Certification Board and American Nurses Credentialing Center accept AMA PRA Category 1 Credit™ issued by organizations accredited by the ACCME (Accreditation Council for Continuing Medical Education). We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The National Commission on Certification of Physician Assistants (NCCPA) states that AMA PRA Category 1 Credits™ are acceptable for continuing medical education requirements for recertification. We would also suggest that learners check with their state licensing board to ensure they accept reciprocity with AMA PRA Category 1 Credit™ for re-licensure.
The American Medical Association (AMA) has an agreement of mutual recognition of continuing medical education (CME) credit with the European Union of Medical Specialties (UEMS). Additional information regarding this agreement may be found on the European Union of Medical Specialties website.
The Royal College of Physicians and Surgeons of Canada recognizes conferences and workshops held outside of Canada that are developed by a university, academy, hospital, specialty society or college as accredited group learning activities.